PRINTO past project details
EPOCA
Juvenile idiopathic arthritis (JIA) is the most common chronic paediatric rheumatic disease and an important cause of short and long-term disability and quality of life impairment.
Due to the disease heterogeneity and the differences in epidemiology, treatment approaches and drug availability, there are likely many differences in the outcome of children with JIA across the world. Although several outcome studies have been published by now, most of these researches have involved single centers or a few countries in the same geographic area and a comparison of the disease outcomes across different regions of the world has never been attempted. Furthermore, most past analysis have focused on single aspects of disease outcome, such as remission, functional disability, radiographic damage, or health-related quality of life and a multidimensional approach in outcome assessment has rarely been pursued. Outcome has not frequently been evaluated through the combination of parent- and physician-centred measures and children self-report of outcome status has rarely been considered. Moreover the disease status has seldom been validated with an objective evaluation performed by the physician.
By involving more than 50 countries belonging to the network of Paediatric Rheumatology INternational Trials Organisation (PRINTO certified ISO 9001-2008, www.printo.it) EPOCA (EPidemiology, treatment and Outcome of Childhood Arthritis) aims to devise a new tool that enables the multidimensional assessment of the disease status in children with JIA. This new instrument, named Juvenile Arthritis Multidimensional Assessment Report (JAMAR), is simple easy to apply and multidimensional in nature. JAMAR′s objectives are to foster the use of standardized quantitative outcome measures in daily care and to enable comparability of outcome data across different centers. Most clinical measures currently used to assess the disease status, particularly functional ability and health-related quality of life questionnaires, are lengthy and complex. According to agreed international guidelines JAMAR will be widely agreed upon and translated, cross-culturally adapted and validated in different languages by the PRINTO coordinators.
Primary objectives
Outcome
- To translate, cross-culturally adapt and validate the JAMAR in the language of each participating countries
- To compare the current outcomes of children with JIA across continents and countries.
Secondary objectives
Epidemiology
-To characterize and compare the frequency of the JIA categories in different countries and in different continents.
-To describe and compare the prevalence of iridocyclitis in different continents and in different countries.
-To define and compare the prevalence of ANA in the different JIA categories across diverse areas of the world.
Treatment
-To compare the treatments used in the management of children with JIA in different countries.
-To obtain information on the access to biologic medications in different countries.
-To compare the same outcomes by disease category.
Outcome
-To promote regular use of quantitative measures, either physician-centred or parent/patient-centred, in the assessment of children with JIA in standard clinical practice.
-To foster uniformity and standardization of clinical assessment of children with JIA across different countries.
At present...
PRINTO is glad to announce that all the 51 papers included in a dedicated supplement of Rheumatology International on Patient’s Reported Outcomes (PRO)s have been finally published on line.
Volume 38, Issue 1 Supplement, April 2018
Supplement: Cross-cultural Adaptation and Validation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) for the Assessment of the Disease Status in Children with Juvenile Idiopathic Arthritis: An International Effort by the Paediatric Rheumatology INternational Trials Organisation (PRINTO)
Rheumathology International - ISSN: 0172-8172 (Print) 1437-160X (Online)
You can find all the manuscripts of the Supplement at the following link:
https://link.springer.com/journal/296/38/1/suppl/page/1
All the manuscripts of the JAMAR Supplement are also available on the PRINTO website and listed below in this page.
The JAMAR supplement contains one paper for each cross-culturally adapted and validated version of the questionnaire (title example: The Italian version of the JAMAR, etc.) and a general introductive manuscript with the description of the methodological approach.
PRINTO finally cross-culturally adapted and validated the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries members of the network.
A total of 9021 JIA patients and 4822 healthy children were enrolled from the 49 countries that took part both in the cross-cultural adaptation phase and in the related validation and data collection: Algeria, Argentina, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, India, Islamic Republic of Iran, Israel, Italy, Latvia, Libya, Lithuania, Mexico, Netherlands, Norway, Oman, Paraguay, Poland, Portugal, Romania, Russian Federation, Saudi Arabia, Serbia, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Thailand, Turkey, Ukraine, United Kingdom and United States of America.
The introductory paper describes the overall methodology, while the results related to each country are fully described by the 282 different authors of the 49 individual manuscripts . The JAMAR was found to have satisfactory psychometric properties and it was thus demonstrated to be a reliable and valid tool for the multidimensional assessment of children with JIA.
The cross-cultural adaptation and validation of the JAMAR could have not been accomplished without the support and the cooperation of the PRINTO members in their local paediatric rheumatology centres, as well as the participation of the families of the JIA patients and healthy controls.
Related articles
van Dijkhuizen EHP, Ridella F, Naddei R, Trincianti C, Avrusin I, Mazzoni M, Sutera D, Ayaz NA, Penades IC, Constantin T, Herlin T, Oliveira SK, Rygg M, Sanner H, Susic G, Sztajnbok F, Varbanova B, Ruperto N, Ravelli A, Consolaro A for the Pediatric Rheumatology International Trials Organization (PRINTO)
Validity and Reliability of Four Parent/Patient-Reported Outcome Measures for Juvenile Idiopathic Arthritis Remote MonitoringArthritis Care Res (Hoboken) Feb;75(2):391-400
Year:
2023 -
Alongi A, Giancane G, Naddei R, Natoli V, Ridella F, Burrone M, Rosina S, Chedeville G, Alexeeva E, Horneff G, Foeldvari I, Filocamo G, Constantin T, Ruperto N, Ravelli A, Consolaro A for the Pediatric Rheumatology International Trials Organization (PRINTO).
Drivers of non-zero physician global scores during periods of inactive disease in juvenile idiopathic arthritis.RDM open 2022 Mar;8(1):e002042
Year:
2022 -
Giancane G, Campone C, Gicchino MF, Alongi A, Bava C, Rosina S, Boyko Y, Martin N, El Miedany Y, Harjacek M, Hashad S, Ioseliani M, Burgos-Vargas R, Joos R, Scott C, Mejbri M, Morel Ayala Z, Ekelund M, Al-Abrawi S, Aiche MF, Norambuena X, Melo-Gomes JA, Ruperto N, Consolaro A, Ravelli A, for the Paediatric Rheumatology International Trials Organization (PRINTO)
Determinants of discordance between criteria for inactive disease and low disease activity in juvenile idiopathic arhritisArthritis Care Res (Hoboken) 2021 Dec;73(12):1722-1729
Year:
2021 -
Consolaro A, Giancane G, Alongi A, van Dijkhuizen EHP, Aggarwal A, Al-Mayouf SM, Bovis F, De Inocencio J, Demirkaya E, Flato B, Foell D, Garay SM, Lazăr C, Lovell DJ, Montobbio C, Miettunen P, Mihaylova D, Nielsen S, Orban I, Rumba-Rozenfelde I, Magalhães CS, Shafaie N, Susic G, Trachana M, Wulffraat N, Pistorio A, Martini A, Ruperto N, Ravelli A for the Paediatric Rheumatology International Trials Organisation (PRINTO)
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort studyLancet Child Adolesc Health 2019 Apr;3(4):255-263
Year:
2019 -
Miettunen P, Chédeville G, Mazza J, Hofer M, Montobbio C, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Canadian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S83–S90
Year:
2018 -
Hofer M, von Scheven-Gête A, Santos M, Quartier P, Wouters C, Vanoni F, Saurenmann RK, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S379–S386
Year:
2018 -
Dehoorne J, Joos R, Wouters C, Swart JF, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Flemish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S187–S194
Year:
2018 -
Nikishina I, Alexeeva E, Arsenyeva S, Salugina S, Kaleda M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Russian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S339–S346
Year:
2018 -
Malagon C, Mosquera Pongutà AC, De Inocencio J, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Colombian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S107–S113
Year:
2018 -
Norambuena X, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Chilean Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S99–S105
Year:
2018 -
Garay SM, Cuttica R, Katsicas MM, Espada G, De Cunto C, Fabi M, Gomez Sosa J, Russo R, Britos M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Argentinian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR).Rheumatol Int 2018;38 (Suppl 1):S51–S58
Year:
2018 -
Pedrosa Fernandes TA, Saad Magalhães C, K Oliveira S, Sztajnbok F, de Oliveira Sato J, Saba Darze L, Gasparello de Almeida R, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Brazilian Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S59–S66
Year:
2018 -
Mihaylova D, Varbanova B, Stefanov S, Teltcharova-Mihaylovska A, Lisichki K, Bojidarova M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Bulgarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S75–S82
Year:
2018 -
Harjacek M, Lamot L, Lamot M, Vidovic M, Paleka Bosak E, Tambic Bukovac L, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Croatian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S115–S122
Year:
2018 -
Doležalová P, Bohm M, Linková L, Saifridová M, Němcová D, Dallos T, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Czech version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S123–S130
Year:
2018 -
Nielsen S, Herlin T, Estmann Christensen A, Zak M, Myrup C, Glerup M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Danish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018; 38 (Suppl 1):S131–S138
Year:
2018 -
El Miedany Y, El Miekkawy D, Youssef SS, El Gaafary M, Nassar N, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Egyptian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S155–S161
Year:
2018 -
Pruunsild C, Ilisson J, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Estonian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S163–S169
Year:
2018 -
Quartier P, Hofer M, Wouters C, Truong TTT, Duong NP, Agbo-Kpati KP, Uettwiller F, Melki I, Mouy R, Bader-Meunier B, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The French Version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018; 38 (Suppl 1):S195–S201
Year:
2018 -
Ioseliani M, Pagava K, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Georgian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S203–S209
Year:
2018 -
Holzinger D, Foell D, Horneff G, Foeldvari I, Tzaribachev N, Tzaribachev C, Minden K, Kallinich T, Ganser G, Clara L, Haas JP, Hügle B, Huppertz HI, Weller F, Consolaro A, Bovis F, Nicolino Ruperto for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The German version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S211–S218
Year:
2018 -
Pratsidou-Gertsi P, Trachana M, Kanakoudi-Tsakalidou F, Tsitsami E, Tsinti M, Vougiouka O, Siamopoulou A, Alfantaki S, Stavrakidou M,Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Greek version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S219–S226
Year:
2018 -
Orbán I, Constantin T, Dérfalvi B, Sevcic K, Garan D, Káposzta R, Poór G, Kiss E, Ponyi A, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S243–S250
Year:
2018 -
Aggarwal A, Khubchandani R, Sawhney S, Rahman M T, Agarwal M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Hindi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S235–S242
Year:
2018 -
Shafaie N, Ziaee V, Aghighi Y, Raeeskarami S R, Moradinejad M H, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Farsi version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S171–S178
Year:
2018 -
Uziel Y, Sherman G, Rabinowicz N, Harel L, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Hebrew version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S227–S233
Year:
2018 -
Consolaro A, Bovis F, Pistorio A, Cimaz R, De Benedetti F, Miniaci A, Corona F, Gerloni V, Martino S, Pastore S, Barone P, Pieropan S, Cortis E, Podda R A, Gallizzi R, Civino A, La Torre F, Rigante D, Consolini R, Maggio M C, Magni-Manzoni S, Perfetti F, Filocamo G, Toppino C, Licciardi F, Garrone M, Scala S, Patrone E, Tonelli M, Tani D, Ravelli A, Martini A, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S251–S258
Year:
2018 -
Rusoniene S, Panaviene V, Jankauskaitė K, Cvilik D, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Lithuanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S275–S282
Year:
2018 -
Gutierrez Suarez R, Burgos-Vargas R, Burgos-Martinez G, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Mexican Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S283–S289
Year:
2018 -
Morel Ayala Z, Burgos-Vargas R, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Paraguayan Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S307–S313
Year:
2018 -
Al-Mayouf SM, AlE’ed A, Muzaffer M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organization (PRINTO)
The Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S43–S49
Year:
2018 -
Susic G, Vojinovic J, Vijatov-Djuric G, Stevanovic D, Lazarevic D, Djurović N, Novakovic D, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Serbian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S347–S354
Year:
2018 -
Vargová V, Dallos T, Leščišinová M, Mrážik P, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Slovak version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S355–S361
Year:
2018 -
Rumba-Rozenfelde I, Saulite I, Rubene A, Razuka-Ebela D, Maija-Butnere M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Latvian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S259–S265
Year:
2018 -
Hashad S, Zletni M A, Al-Mayouf S M, Etayari H, Abdalla EIAA, Etfil M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Libyan Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S267–S274
Year:
2018 -
Wulffraat N, Kamphuis S, Swart J F, Vastert S, Van Dijkhuizen P, van Pelt P, van Dijk-Hummelman A, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Dutch version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S139–S146
Year:
2018 -
Flato B, Rygg M, Nordal E B, Røisland M, Ødegård H B, Hoftun G B, Songstad N T, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S291–S298
Year:
2018 -
Al-Abrawi S, Al-Mayouf S M, Abdwani R, Abdalla E I A A, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Omani Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;8 (Suppl 1):S299–S306
Year:
2018 -
Rutkowska-Sak L, Smolewska E, Zygmunt A, Kwiatkowska M, Gazda A, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Polish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S315–S321
Year:
2018 -
Lazăr C, Iagăru N, Ailioaie C, Ailioaie LM, Laday M, Apostol A, Spîrchez M, Badiu Tișa I, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Romanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S331–S338
Year:
2018 -
Toplak N, Avcin T, Camernik M, Hren M, Sever M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Slovene version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S363–S369
Year:
2018 -
Scott C, Okong’o L, Brice N, Murless S, Slamang W, Fadlelmola A, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Afrikaans version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S19–S26
Year:
2018 -
De Inocencio J, Anton J, Calvo Penades I, Mesa-del-Castillo P, Alcobendas R, Boteanu AL, Bou R, Iglesias E, González Fernandez MI, López Montesinos B, Santin P, Alcañiz Rodriguez P, Lorente Sanchez MJ, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Castilian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S91–S98
Year:
2018 -
Ekelund M, Berntson L, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Swedish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S371–S377
Year:
2018 -
Vilaiyuk S, Soponkanaporn S, Lerkvaleekul B, Pipatkullachart T, Mairiang D, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Thai version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S387–S393
Year:
2018 -
Boyko Y, Hrytsiuk I, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Ukrainian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S403–S409
Year:
2018 -
Martin N, Davidson J, Anderson C, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The British English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S67–S73
Year:
2018 -
Lovell DJ, Brunner HI, Ringold S, Weiss PF, Martin N, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The American English version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S35–S42
Year:
2018 -
Bovis F, Consolaro A, Pistorio A, Garrone M, Scala S, Patrone E, Rinaldi M, Villa L, Martini A, Ravelli A, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: review of the general methodologyRheumatol Int 2018;38 (Suppl 1):S5–S17
Year:
2018 -
Herrera Mora C, Garay SM, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Ecuadorian Spanish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S147–S153
Year:
2018 -
Aiche MF, Djoudi H, Al-Mayouf SM, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Algerian Arabic version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Rheumatol Int 2018;38 (Suppl 1):S27–S33
Year:
2018 -
Demirkaya E, Ozen S, Sozeri B, Aktay Ayaz N, Kasapcopur O, Unsal E, Bora Makay B, Barut K, Fidanci BE, Simsek D, Cakan M, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Turkish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S395–S402
Year:
2018 -
Lahdenne P, Aalto K, Rebane K, Vahasalo P, Putto-Laurila AK, Malin M, Kroger L, Saila H, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S179–S186
Year:
2018 -
Melo-Gomes JA, Oliveira-Ramos F, Consolaro A, Bovis F, Ruperto N for the Paediatric Rheumatology International Trials Organisation (PRINTO)
The Portuguese version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Rheumatol Int 2018;38 (Suppl 1):S323–S329
Year:
2018 -
Ravelli A, Consolaro A, for the Epidemiology, treatment and Outcome of Childhood Arthritis (EPOCA) project; Martini A and Ruperto N, for the Paediatric Rheumatology International Trials Organisation (PRINTO)
Preface to the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) Supplement in Rheumatology InternationalRheumatol Int 2018;38 (Suppl 1):S1–S3
Year:
2018 -
Consolaro A, Ruperto N, Filocamo G, Lanni S, Bracciolini G, Garrone M, Scala S, Villa L, Silvestri G, Tani D, Zolesi A, Martini A, Ravelli A for the Paediatric Rheumatology International Trials Organisation (PRINTO).
Seeking insights into the EPidemiology, treatment and Outcome of Childhood Arthritis through a multinational collaborative effort: Introduction of the EPOCA study.Pediatric Rheumatology 2012;10:39.
Year:
2012 -
Consolaro A, Ruperto N, Pistorio A, Lattanzi B, Solari N, Galasso R, Pederzoli S, Varnier GC, Dolezalova P, Alessio M, Burgos-Vargas R, Vesely R, Martini A, Ravelli A for the Paediatric Rheumatology International Trials Organisation (PRINTO).
Development and initial validation of composite parent and child centered disease assessment indices for juvenile idiopathic arthritis.Arthritis Care Res 2011;63:1262-1270
Year:
2011 -